Investigators found that the tumours displayed reduced infiltration with CD45+ myeloid cells, diminished angiogenic activity, and persistent shrinkage with no regrowth, which may result from insufficient MMP-9 to induce neovascularization. This evidence concerns the gene PTPRC and neoplasm.